Stock Research: Fresenius Medical Care

Peer-based, data-driven stock research by Obermatt enables quick and easy due diligence for your stock investing.

What's New

Recent improvements to enhance your investment research experience

360° View free for everyone

Our most comprehensive analysis—the 360° View—is now free for everyone. To maintain our research quality, other ranks are now part of our new subscription plans.

3 new subscription models

Plans for every investor - from stock ideas to in-depth analysis.

Similar Stocks

Four stock alternatives to the stock you're searching.

Fresenius Medical Care

XTRA:FME DE0005785802
81
  • Value
    55
  • Growth
    53
  • Safety
    Safety
    89
  • Combined
    83
  • Sentiment
    59
  • 360° View
    360° View
    81
Unlock
Which ranks are driving this 360° View?
Subscribe to View
Company Description

Fresenius Medical Care AG is a Germany-based kidney dialysis institute providing dialysis care and related services for end-stage renal disease (ESRD) and other extracorporeal therapies. It operates in healthcare services, including R&D, manufacturing, supply chain, and commercial operations, developing both dialysis and non-dialysis products. In the last fiscal year, the company had a market cap of $15757 million, profits of $4925 million, revenue of $20019 million, and 111513 employees.

more
Analysis

ANALYSIS: With an Obermatt 360° View of 81 (better than 81% compared with alternatives) for 2025, overall professional sentiment and financial characteristics for the stock Fresenius Medical Care are very positive. The 360° View is based on consolidating four consolidated indicators, with all four indicators above average for Fresenius Medical Care. The consolidated Value Rank has an attractive rank of 89, which means that the share price of Fresenius Medical Care is on the lower side compared with the typical size in indicators such as revenues, profits, and invested capital. This means the stock price is lower than for 89% of alternative stocks in the same industry. The consolidated Growth Rank has a good rank of 53, which means that the company experiences above-average growth momentum when looking at financial metrics such as revenue, profit, and invested capital growth as well as stock returns. The company is also safely financed with a Safety rank of 55. Finally, professional market sentiment is above average compared with other stock investment alternatives with a Sentiment Rank of 59. ...read more

more
Index
CDAX
DAX 40
Dividends Europe
Human Rights
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 16-Oct-2025.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
89 88 83 89
Growth
53 38 31 27
Safety
Safety
55 61 74 41
Sentiment
59 58 23 9
360° View
360° View
81 81 54 31
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Analyst Opinions
21 13 8 21
Opinions Change
48 65 53 29
Pro Holdings
n/a 51 24 46
Market Pulse
74 81 64 34
Sentiment
59 58 23 9
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
89 88 83 89
Growth
53 38 31 27
Safety Safety
55 61 74 41
Combined
83 83 82 61
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Price vs. Sales (P/S)
84 77 77 89
Price vs. Earnings (P/E)
71 69 72 75
Price vs. Book (P/B)
86 82 84 84
Dividend Yield
83 77 74 84
Value
89 88 83 89
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Revenue Growth
16 29 10 32
Profit Growth
75 39 8 6
Capital Growth
31 42 82 84
Stock Returns
81 82 83 27
Growth
53 38 31 27
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Leverage
35 31 38 24
Refinancing
76 77 77 47
Liquidity
33 42 42 39
Safety Safety
55 61 74 41

Similar Stocks

Discover high‑ranked alternatives to Fresenius Medical Care and broaden your portfolio horizons.

KSB

XTRA:KSB
Country: Germany
Industry: Industrial Machinery
Size: Medium
Full Stock Analysis

Continental

XTRA:CON
Country: Germany
Industry: Auto Parts & Equipment
Size: X-Large
Full Stock Analysis

Drägerwerk

XTRA:DRW3
Country: Germany
Industry: Health Care Equipment
Size: Medium
Full Stock Analysis

Bilfinger

XTRA:GBF
Country: Germany
Industry: Diversified Support Services
Size: Medium
Full Stock Analysis

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.